help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tyson, D. R.
Right arrow Articles by Partridge, N. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tyson, D. R.
Right arrow Articles by Partridge, N. C.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*L-SERINE
*LITHIUM CHLORIDE
*LITHIUM COMPOUNDS
*PARATHYROID HORMONE
Endocrinology Vol. 143, No. 2 674-682
Copyright © 2002 by The Endocrine Society


PTH-CALCITONIN-VITAMIN D-BONE

PTH Induction of Transcriptional Activity of the cAMP Response Element-Binding Protein Requires the Serine 129 Site and Glycogen Synthase Kinase-3 Activity, But Not Casein Kinase II Sites

Darren R. Tyson1,2, John T. Swarthout2, Stephen C. Jefcoat and Nicola C. Partridge

Cell and Molecular Biology Program and Department of Pharmacological and Physiological Science, St. Louis University School of Medicine, St. Louis, Missouri 63104; and Department of Physiology and Biophysics, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, Piscataway, New Jersey 08854

Address all correspondence and requests for reprints to: Dr. Nicola C. Partridge, Department of Physiology and Biophysics, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, 675 Hoes Lane, Piscataway, New Jersey 08854. E-mail: partrinc{at}umdnj.edu

We have previously shown that PTH induction of c-fos expression in the rat osteoblastic cell line UMR 106-01 requires the phosphorylation of cAMP response element-binding protein (CREB) at serine 133. Here we show that this event is not sufficient for induced transcriptional activity in UMR cells. Serine 129, but not the casein kinase II sites (serines 108, 111, 114, 117, and 121), also plays a role in the activation of CREB. First, by metabolically labeling an epitope-tagged CREB, we determined that, in addition to serine 133, other residues are phosphorylated in vivo. Using mutational analysis of a GAL4-CREB reporter system we demonstrate that serines 129 and 133 are both required for PTH-induced transcriptional activity, whereas the casein kinase II sites are not. Furthermore, PTH failed to induce transcriptional activity of GAL4-CREB in cells treated with genistein, a general tyrosine kinase inhibitor known to inhibit glycogen synthase kinase-3 (GSK-3) activity, or LiCl, the most specific GSK-3-inhibiting agent known, strongly implicating GSK-3ß in this process. Importantly, although genistein and LiCl each inhibit GSK-3ß activity, neither prevented the phosphorylation of serine 133 induced by PTH. Lastly, when serine 129 is replaced with a negatively charged aspartic acid, LiCl has no effect on the PTH-induced trans-activation of CREB. We propose that GSK-3ß phosphorylates CREB at serine 129 and thus is required for the increased transcriptional activity of CREB in response to PTH.




This article has been cited by other articles:


Home page
J. Neurosci.Home page
H. Dou, B. Ellison, J. Bradley, A. Kasiyanov, L. Y. Poluektova, H. Xiong, S. Maggirwar, S. Dewhurst, H. A. Gelbard, and H. E. Gendelman
Neuroprotective Mechanisms of Lithium in Murine Human Immunodeficiency Virus-1 Encephalitis
J. Neurosci., September 14, 2005; 25(37): 8375 - 8385.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
I. C. Ozkurt, F. Q. Pirih, and S. Tetradis
Parathyroid Hormone Induces E4bp4 Messenger Ribonucleic Acid Expression Primarily through Cyclic Adenosine 3',5'-Monophosphate Signaling in Osteoblasts
Endocrinology, August 1, 2004; 145(8): 3696 - 3703.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
W. B. Sneddon, C. E. Magyar, G. E. Willick, C. A. Syme, F. Galbiati, A. Bisello, and P. A. Friedman
Ligand-Selective Dissociation of Activation and Internalization of the Parathyroid Hormone (PTH) Receptor: Conditional Efficacy of PTH Peptide Fragments
Endocrinology, June 1, 2004; 145(6): 2815 - 2823.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
X. Chen, J.-C. Dai, and E. M. Greenfield
Termination of immediate-early gene expression after stimulation by parathyroid hormone or isoproterenol
Am J Physiol Cell Physiol, November 1, 2002; 283(5): C1432 - C1440.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
D. R. Vyas, E. E. Spangenburg, T. W. Abraha, T. E. Childs, and F. W. Booth
GSK-3beta negatively regulates skeletal myotube hypertrophy
Am J Physiol Cell Physiol, August 1, 2002; 283(2): C545 - C551.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2002 by The Endocrine Society